181
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Current status of lung cancer in Spain: a retrospective analysis of patient characteristics, use of healthcare resources and in-hospital mortality

&
Pages 1201-1207 | Received 03 Feb 2020, Accepted 02 May 2020, Published online: 15 May 2020

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Global Cancer Observatory. International Agency for Research on Cancer; World Health Organization [Internet]. [cited 2019 Jul]. Available from https://gco.iarc.fr
  • Sociedad Española de Oncología Médica. Las cifras del cáncer en España [Cancer figures in Spain] [Internet]. [cited 2019 Jul]. Available from https://seom.org/dmcancer/las-cifras-del-cancer-en-espana-2019/ [Spanish].
  • Galceran J, Ameijide A, Carulla M, et al. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19(7):799–825.
  • Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
  • Clèries R, Esteban L, Borràs J, et al. Time trends of cancer incidence and mortality in Catalonia during 1993-2007. Clin Transl Oncol. 2014;16(1):18–28.
  • Linares I, Molina-Portillo E, Expósito J, et al. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study. Clin Transl Oncol. 2016;18(5):489–496.
  • Remon J, Molina-Montes E, Majem M, et al. Lung cancer in women: an overview with special focus on Spanish women. Clin Transl Oncol. 2014;16(6):517–528.
  • Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer. 2012;131(12):2724–2732.
  • World Health Organization. Radon and health [Internet]. [cited 2019 Dec]. Available from https://www.who.int/news-room/fact-sheets/detail/radon-and-health
  • Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902.
  • Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016; 170:25–46.
  • Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–1380.
  • Shen H. Low-dose CT for lung cancer screening: opportunities and challenges. Front Med. 2018;12(1):116–121.
  • Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;18(12):e754–e66.
  • Katkade VB, Sanders KN, Zou KH. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc. 2018;11:295–304.
  • Justo N, Espinoza MA, Ratto B, et al. Real-world evidence in healthcare decision making: global trends and case studies From Latin America. Value Health. 2019;22(6):739–749.
  • Law 14/2007, 3rd July, on biomedical research (BOE, 4 July 2007). Rev Derecho Genoma Hum. 2007;(26):283–325.
  • Ministerio de Sanidad, Consumo y Bienestar Social. Sanidad en datos [Health figrues] [Internet]. [cited 2019 Dec]. https://www.mscbs.gob.es/estadEstudios/sanidadDatos/home.htm [Spanish].
  • Law 28/2005, 26th December, regarding health measures against tobacco addiction and regulating sales, supplies, consumption and advertising of tobacco products. Boletín Oficial Del Estado (Boe). 2005;309:42241–42250.
  • Law 42/2010, 30th December, modifying law 28/2005, 26th December, regarding health measures against tobacco addiction and regulating sales, supplies, consumption and advertising of tobacco products. Boletín Oficial Del Estado (Boe). 2010;318:109188–109194.
  • Mendoza R, López Pérez P, Sagrera MR. Gender differences in the evolution of adolescent’s tobacco consumption in Spain (1986-2002). Adicciones. 2007;19(3):273–287.
  • Houston KA, Mitchell KA, King J, et al. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county. J Thorac Oncol. 2018;13(4):497–509.
  • Zhang Y, Ren JS, Huang HY, et al. International trends in lung cancer incidence from 1973 to 2007. Cancer Med. 2018;7(4):1479–1489.
  • Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594.
  • Bilfinger TV, Albano D, Perwaiz M, et al. Survival outcomes among lung cancer patients treated using a multidisciplinary team approach. Clin Lung Cancer. 2018;19(4):346–351.
  • Bonfill X, Moreno C, Prada G, et al. Lung cancer mortality among males of Catalonia and Spain compared with other European countries between 1975-1977 and 1987-1989. Int J Cancer. 1996;65(6):751–754.
  • López-Campos JL, Ruiz-Ramos M, Fernandez E, et al. Recent lung cancer mortality trends in Europe: effect of national smoke-free legislation strengthening. Eur J Cancer Prev. 2018;27(4):296–302.
  • Parés-Badell O, Banqué M, Macià F, et al. Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol. 2017;49:66–74.
  • Provencio M, Carcereny E, Rodríguez-Abreu D, et al. Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study). Transl Lung Cancer Res. 2019;8(4):461–475.
  • Akhtar N, Bansal JG. Risk factors of lung cancer in nonsmoker. Curr Probl Cancer. 2017;41(5):328–339.
  • García-Lavandeira JA, Ruano-Ravina A, Barros-Dios JM. Alcohol consumption and lung cancer risk in never smokers. Gac Sanit. 2016;30(4):311–317.
  • Zhu L, Cao H, Zhang T, et al. The effect of diabetes mellitus on lung cancer prognosis: a PRISMA-compliant meta-analysis of cohort studies. Medicine (Baltimore). 2016;95(17):e3528.
  • Luo J, Hendryx M, Qi L, et al. Pre-existing diabetes and lung cancer prognosis. Br J Cancer. 2016;115(1):76–79.
  • Gildea TR, DaCosta Byfield S, Hogarth DK, et al. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. CEOR. 2017;9:261–269.
  • Goldsbury DE, Yap S, Weber MF, et al. Health services costs for cancer care in Australia: estimates from the 45 and Up Study. PLoS One. 2018;13(7):e0201552.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.